Jiahui Health: An International Healthcare Ecosystem in Shanghai

Jiahui Health is an international healthcare ecosystem in China. It is built on a three-dimensional structure of “international hospital + family clinics + health centers,” aiming to provide international-quality medical services across the full life cycle for individuals and families.

The core institution of Jiahui Health is Shanghai Jiahui International Hospital, located in Xuhui District, Shanghai. The hospital officially began operation in October 2017. From design to construction, it followed FGI and JCI international standards and was built as an advanced medical complex with strong attention to international healthcare quality and patient experience.

Jiahui Health has established a deep strategic collaboration with Massachusetts General Hospital, a teaching hospital affiliated with Harvard Medical School. Through this cooperation, Jiahui Health connects international medical resources with high-quality domestic medical services, allowing patients in China to access international-level medical support closer to home.

As an innovative international healthcare ecosystem, Jiahui Health has long focused on integrated development in medical care, education, and research. It continues to connect overseas medical expertise, local specialist resources, and modern hospital management systems to support high-quality healthcare delivery in China.

Shanghai Jiahui International Hospital has 500 approved beds and a building area of approximately 180,000 square meters. It currently operates more than 30 clinical departments, providing services from health management, outpatient and emergency care to complex surgery, inpatient treatment, and overseas referral support.

The hospital has three major clinical centers of excellence: Jiahui International Cancer Center, Orthopedics and Sports Medicine Center, and Women’s Health Center. Its featured specialties cover oncology, women’s health, pediatrics, orthopedics, sports medicine, cardiology, general internal medicine, and medical imaging.

Jiahui International Cancer Center has developed strong capabilities in cancer care, especially in hematologic oncology. The center has built one of the region’s highly international CAR-T treatment teams, and patients from China and overseas have chosen Jiahui for CAR-T treatment support.

Jiahui Health also provides advanced examination and treatment options, including PET-CT, genetic testing, coronary CTA, and other high-end diagnostic services. In the field of oncology, the hospital has advanced treatment capabilities such as CAR-T cell immunotherapy.

Jiahui Health currently has more than 1,500 employees. Its medical team comes from well-known medical institutions in China and overseas, and around 20% of the team are international staff members. Based on the strategic collaboration with Massachusetts General Hospital, several experts practice jointly at Shanghai Jiahui International Hospital and Massachusetts General Hospital.

Jiahui Health also continues to introduce experienced doctors from leading Grade III hospitals in China. Its expert team covers oncology, cardiology, medical imaging, neurology, general practice, thoracic surgery, and other major fields, supporting a multidisciplinary and international-standard care model.

Jiahui Health has built a multi-level medical network centered on a tertiary comprehensive international hospital, combined with secondary diagnosis and treatment, community-based primary care, and internet medical services. This structure supports patients across different stages of care and health management.

The hospital has opened direct billing with more than 40 mainstream global insurance companies and is connected to Shanghai medical insurance, supporting convenient combined payment through medical insurance and commercial insurance. Jiahui International Hospital was also the only designated international hospital for the China International Import Expo for three consecutive years from 2018 to 2020.

Jiahui Health has established a clinical trial institution and works with academic institutions and enterprises to conduct high-level clinical research. Its research coverage includes oncology, imaging, cardiology, and other medical fields.

J-MED, the Jiahui Medical Research and Education Group, manages and exclusively operates the Chinese edition of The New England Journal of Medicine, providing authoritative, cutting-edge, and evidence-based medical education resources for healthcare professionals. Its sister company also provides personalized precision clinical solutions for cancer patients and physicians in China.

Jiahui International Hospital was selected as one of the 18 designated medical institutions for the first China International Import Expo in 2018, becoming the only international hospital on the list. It continued to provide medical support for the CIIE for three consecutive years.

Jiahui Health has long supported the localized practice of high-quality international healthcare in China. It focuses on international and advanced treatment concepts, medicines, and technologies, aiming to benefit both domestic and international patients through trustworthy, patient-centered, and full-life-cycle care.

"Jiahui Health connects international medical standards, local clinical resources, and full-life-cycle care to support individuals and families with trusted healthcare in China."